Atlas Trials

OMEGA Study: A Study of the Safety and Feasibility of Up-titration With INT301 in Adults With Sensitivity to Peanut

Clinical trial NCT04603300 · COMPLETED

Trial details

NCT number
NCT04603300
Sponsor
Intrommune Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Peanut Allergy
Start date
2021-05-15
Primary completion
2023-06-30
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.